Clinical Trial Update: An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer

View source ↗

Summary

Sanofi's open-label expanded-access protocol for iniparib in breast cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Iniparib (iparib)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer | Status: NO_LONGER_AVAILABLE